What does CUSIP 55234L105 represent in this 13F holders report?

CUSIP 55234L105 is the security identifier for LYRA - Lyra Therapeutics, Inc. - Common Stock, $0.001 par value used to aggregate holder disclosures.

How many institutions held LYRA - Lyra Therapeutics, Inc. - Common Stock, $0.001 par value in Q4 2020?

43 institutional investors reported LYRA - Lyra Therapeutics, Inc. - Common Stock, $0.001 par value for Q4 2020. Use the holders table for investor-level position and value details.

Lyra Therapeutics, Inc. - Common Stock, $0.001 par value (LYRA)

CUSIP: 55234L105

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class: Equity / Common Stock, $0.001 par value
Shares outstanding: 1,644,695
Total 13F shares: 8,595,912
Share change: +884,291
Total reported value: $97,990,000
Price per share: $11.40
Number of holders: 43
Value change: +$10,187,234
Number of buys: 30
Number of sells: 9

Quarterly Holders Quick Answers

What is CUSIP 55234L105?
CUSIP 55234L105 identifies LYRA - Lyra Therapeutics, Inc. - Common Stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2021
Previous quarter: Q3 2020

Recent filing periods for CUSIP 55234L105:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Top shareholders of LYRA - Lyra Therapeutics, Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
PERCEPTIVE ADVISORS LLC	13F	Company	196%	3,222,561	$36,028,000	—	30 Sep 2020	13F
Polaris Venture Management Co. V, L.L.C.	13F	Company	67%	1,100,852	$12,308,000	—	30 Sep 2020	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	50%	815,849	$9,252,000	—	30 Sep 2020	13F
ArrowMark Colorado Holdings LLC	13F	Company	48%	788,215	$8,812,000	—	30 Sep 2020	13F
Ikarian Capital, LLC	13F	Company	24%	387,939	$4,338,000	—	30 Sep 2020	13F
PURA VIDA INVESTMENTS, LLC	13F	Company	14%	226,703	$2,535,000	—	30 Sep 2020	13F
BlackRock Finance, Inc.	13F	Company	13%	207,326	$2,317,000	—	30 Sep 2020	13F
Invesco Ltd.	13F	Company	12%	197,776	$2,211,000	—	30 Sep 2020	13F
VANGUARD GROUP INC	13F	Company	9.2%	151,625	$1,695,000	—	30 Sep 2020	13F
Soleus Capital Management, L.P.	13F	Company	6.7%	110,670	$1,237,000	—	30 Sep 2020	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	3.8%	61,710	$690,000	—	30 Sep 2020	13F
NORTHERN TRUST CORP	13F	Company	3%	48,887	$547,000	—	30 Sep 2020	13F
STATE STREET CORP	13F	Company	2.8%	45,506	$509,000	—	30 Sep 2020	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	2.7%	43,664	$488,000	—	30 Sep 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	2.5%	40,510	$452,000	—	30 Sep 2020	13F
Ensign Peak Advisors, Inc	13F	Company	2.4%	39,167	$438,000	—	30 Sep 2020	13F
FEDERATED HERMES, INC.	13F	Company	1.8%	30,000	$335,000	—	30 Sep 2020	13F
Pentwater Capital Management LP	13F	Company	1.4%	23,800	$266,000	—	30 Sep 2020	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	1.3%	21,697	$243,000	—	30 Sep 2020	13F
BANK OF AMERICA CORP /DE/	13F	Company	1.1%	18,902	$212,000	—	30 Sep 2020	13F
NISA INVESTMENT ADVISORS, LLC	13F	Company	0.99%	16,210	$181,000	—	30 Sep 2020	13F
Bank of New York Mellon Corp	13F	Company	0.95%	15,643	$175,000	—	30 Sep 2020	13F
Russell Investments Group, Ltd.	13F	Company	0.83%	13,688	$153,000	—	30 Sep 2020	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.38%	6,194	$69,000	—	30 Sep 2020	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.27%	4,438	$50,000	—	30 Sep 2020	13F
Tower Research Capital LLC (TRC)	13F	Company	0.25%	4,080	$46,000	—	30 Sep 2020	13F
AMERICAN INTERNATIONAL GROUP, INC.	13F	Company	0.15%	2,457	$28,000	—	30 Sep 2020	13F
DEUTSCHE BANK AG\	13F	Company	0.13%	2,087	$23,000	—	30 Sep 2020	13F
JPMORGAN CHASE & CO	13F	Company	0.12%	1,918	$22,000	—	30 Sep 2020	13F
STRS OHIO	13F	Company	0.07%	1,100	$12,000	—	30 Sep 2020	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.07%	1,083	$12,000	—	30 Sep 2020	13F
OSAIC HOLDINGS, INC.	13F	Company	0.06%	975	$11,000	—	30 Sep 2020	13F
UBS Group AG	13F	Company	0.05%	848	$9,000	—	30 Sep 2020	13F
MORGAN STANLEY	13F	Company	0.04%	683	$8,000	—	30 Sep 2020	13F
Legal & General Group Plc	13F	Company	0.02%	395	$4,000	—	30 Sep 2020	13F
CITIGROUP INC	13F	Company	0.02%	393	$4,000	—	30 Sep 2020	13F
Ameritas Investment Partners, Inc.	13F	Company	0.02%	363	$4,000	—	30 Sep 2020	13F
US BANCORP \DE\	13F	Company	0.02%	300	$3,000	—	30 Sep 2020	13F
BANK OF MONTREAL /CAN/	13F	Company	0.01%	189	$2,000	—	30 Sep 2020	13F

Institutional Holders of Lyra Therapeutics, Inc. - Common Stock, $0.001 par value (LYRA) as of Q4 2020

As of 31 Dec 2020, Lyra Therapeutics, Inc. - Common Stock, $0.001 par value (LYRA) was held by 43 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 8,595,912 shares. The largest 10 holders included PERCEPTIVE ADVISORS LLC, Polaris Venture Management Co. V, L.L.C., RA CAPITAL MANAGEMENT, L.P., Ikarian Capital, LLC, ArrowMark Colorado Holdings LLC, Soleus Capital Management, L.P., BlackRock Inc., JPMORGAN CHASE & CO, VANGUARD GROUP INC, and BOOTHBAY FUND MANAGEMENT, LLC. This page lists 43 institutional shareholders reporting positions in this security for the Q4 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2020 vs Q3 2020 Across Filers

Q3 2020 holders

Q4 2020 holders

Holder diff

Investor	Q3 2020 Shares	Q4 2020 Shares	Share Diff	Share Chg %	Q3 2020 Value $	Q4 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.